LYON, France and CAMBRIDGE, Mass., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, has been awarded ‘Biotech Company of the Year 2023’ at the annual LSX, European Lifestars Awards Ceremony, held on November 13th in London, U.K.
See the original post here:
Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards
Recommendation and review posted by G. Smith
